New combo therapy targets tough lung cancer in early trial
NCT ID NCT05595460
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests a new drug called RYZ101 added to standard chemotherapy and immunotherapy for people with a specific type of advanced small cell lung cancer that has spread. The main goals are to check safety and find the best dose. About 21 adults who have not had treatment yet will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCLC, EXTENSIVE STAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Facility
Los Angeles, California, 90024, United States
-
Research Facility
San Francisco, California, 94158, United States
-
Research Facility
Jacksonville, Florida, 32224, United States
-
Research Facility
Miami, Florida, 33136, United States
-
Research Facility
Orlando, Florida, 32806, United States
-
Research Facility
Iowa City, Iowa, 52242, United States
-
Research Facility
Grand Rapids, Michigan, 49503, United States
-
Research Facility
Rochester, Minnesota, 55905, United States
-
Research Facility
St Louis, Missouri, 63130, United States
-
Research Facility
Omaha, Nebraska, 68130, United States
-
Research Facility
Salt Lake City, Utah, 84112, United States
-
Research Facility
San Juan, Puerto Rico, 00935, Puerto Rico
-
Reserach Facility
Lexington, Kentucky, 40536, United States